SOMERVILLE, MA, UNITED STATES, May 15, 2026 /EINPresswire.com/ -- In the specialized fields of drug discovery and ...

Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...

OpenAI Has a New AI Model Built for Biology and Science ...

Perth biotech Syngenis is using AI to slash the time and cost of discovering RNA therapies, targeting a booming global market ...

At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous iterations of GPT excelled at general language tasks, this model is fine-tuned for ...

TrilliumBiO, a leader in biomarker discovery and precision diagnostics, and Oncobit, a Swiss precision oncology company, ...

OpenProtein.AI, a leader in AI-powered protein engineering software, today announced it has been selected as a performer on the Defense Advanced Research Projects Agency's (DARPA) Network of Optimal ...

Progressing toward commercialization with third-party head-to-head data publications and GALACTIC registry study engagementNortheast kidney ...

Scientists at Cleveland Clinic, RIKEN, and IBM (NYSE: IBM) have used IBM quantum computers and two of the world's most ...

Q1 2026 Management View "Since submitting GraftAssureDx to the FDA in late March, we've had a high degree of engagement from them and expect that, that will continue as we move through the review ...

10x Science has raised a $4.8 million seed round to help pharmaceutical researchers understand complex molecules.

He was brainstorming ideas with an artificial-intelligence tool and getting it to code and create them quickly. Together, ...